Article
Rheumatology
Beatriz Tejera Segura, Irene Altabas Gonzalez, Inigo Rua-Figueroa, Natalia Perez Veiga, Victor Del Campo Perez, Alejandro Olive-Marques, Maria Galindo, Jaime Calvo, Juan Gabriel Ovalles-Bonilla, Antonio Fernandez-Nebro, Raul Menor-Almagro, Eva Tomero, Natividad del Val del Amo, Esther Uriarte Isacelaya, Victor Manuel Martinez-Taboada, Jose L. Andreu, Alina Boteanu, Javier Narvaez, Atusa Movasat, Carlos Montilla, Jose Miguel Senabre Gallego, Blanca Hernandez-Cruz, Mariano Andres, Eva Salgado, Mercedes Freire, Sergio Machin Garcia, Clara Moriano, Lorena Exposito, Clara Perez Velasquez, M. L. Velloso-Feijoo, Ana Paula Cacheda, Nuria Lozano-Rivas, Gema Bonilla, Marta Arevalo, Inmaculada Jimenez, Victor Quevedo-Vila, Francisco J. Manero-Ruiz, Paloma Garcia de la Pena Lefebvre, Tomas Ramon Vazquez-Rodriguez, Jesus Ibanez-Rua, Tatiana Cobo-Ibanez, Jose Maria Pego-Reigosa
Summary: The study investigates gastrointestinal manifestations in SLE patients and finds that those with GI damage typically have more severe disease, longer disease duration, higher likelihood of organ involvement, and higher mortality rates.
Review
Chemistry, Medicinal
Salvatore Di Bartolomeo, Alessia Alunno, Francesco Carubbi
Summary: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with a wide range of clinical manifestations. The respiratory system can be involved in up to 50-70% of patients, with varying severity and treatment approaches depending on specific patterns.
Review
Biochemistry & Molecular Biology
Wojciech Lubon, Malgorzata Lubon, Przemyslaw Kotyla, Ewa Mrukwa-Kominek
Summary: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease, with up to one-third of patients experiencing various ocular manifestations. Ocular findings may be the initial signs of the disease and can lead to severe complications and vision loss. Early diagnosis and proper management are crucial, requiring collaboration among specialists. Adequate preparation of ophthalmologists can help differentiate SLE complications from other eye disorders. New therapies for SLE show promise, but their ocular side effects are still unknown.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Dentistry, Oral Surgery & Medicine
Merve Benli, Fareeha Batool, Celine Stutz, Catherine Petit, Sophie Jung, Olivier Huck
Summary: Studies have shown that SLE patients are at higher risk of compromised oral and dental health, with an increased risk of periodontal diseases and temporomandibular joint disorders. The use of systemic drugs, especially immunosuppressive and anticoagulants in SLE patients, may impact their oral management. Results emphasize the importance of early appropriate oral management of these patients to improve oral health-related quality of life and prevent the need for more invasive therapeutics. A multidisciplinary approach is necessary for the dental and medical management of such patients.
Review
Pediatrics
Thomas Dowsett, Louise Oni
Summary: This review article summarizes the current literature surrounding the management of pediatric lupus nephritis. The current treatment approach involves induction therapy to induce remission followed by maintenance immunosuppressive therapy. However, the complete response rates in lupus nephritis are still inadequate and disease flares are common. Progression to chronic kidney disease is also a concern. Current clinical trials are focused on the use of biologic agents as adjuncts to current therapy. Improved outcomes in pediatric lupus nephritis are urgently needed and the use of biomarkers and scientific studies offer hope for better understanding and management.
CURRENT OPINION IN PEDIATRICS
(2022)
Article
Medicine, General & Internal
Xiao Wang, Qiang Shu, Lijun Song, Qi Liu, Xiaoxia Qu, Ming Li
Summary: This study compared the diversity and composition of gut microbiota in SLE patients and their healthy family members, and found that SLE patients had lower diversity and specific bacterial taxa in their gut microbiota, which were associated with the clinical manifestations and diet of SLE.
FRONTIERS IN MEDICINE
(2022)
Article
Rheumatology
Laurent Arnaud, Philippe Mertz, Zahir Amoura, Reinhard E. Voll, Andreas Schwarting, Francois Maurier, Gilles Blaison, Bernard Bonnotte, Vincent Poindron, Christoph Fiehn, Hanns-Martin Lorenz, Anne-Sophie Korganow, Jean Sibilia, Thierry Martin
Summary: This study utilized latent class analysis to identify three distinct patterns of fatigue in a large international cohort of SLE patients, highlighting the importance of distinguishing between patients with active disease and those with high levels of fatigue, depression, and anxiety for appropriate treatment prioritization.
Review
Immunology
Paul Curtiss, Amanda M. Walker, Benjamin F. Chong
Summary: This study reviewed patient cohorts and populations to investigate the progression of cutaneous lupus to systemic lupus. The study found variations in the progression rates between adult and pediatric groups, which were attributed to differences in patient populations, study design, diagnostic criteria, and follow-up time. Risk factors associated with the development of systemic lupus included positive anti-nuclear antibodies, hematologic abnormalities, and a higher number of lupus classification criteria at baseline.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Medicine, General & Internal
Raj Amarnani, Su-Ann Yeoh, Emma K. Denneny, Chris Wincup
Summary: Pulmonary manifestations of systemic lupus erythematosus (SLE) can range from lung parenchymal disorders to pleural and pulmonary vasculature diseases. The risks of respiratory infections are increased by immunosuppressive treatment, and some patients may be asymptomatic. Treatment decisions are often based on case reports or experiences from other autoimmune rheumatic diseases.
FRONTIERS IN MEDICINE
(2021)
Review
Rheumatology
S. Trapani, C. Rubino, G. Simonini, G. Indolfi
Summary: Gastrointestinal involvement in pediatric-onset SLE is mainly characterized by lupus enteritis, with early diagnosis and treatment being crucial for improving prognosis. Further studies are needed to explore the prevalence, prognosis, and treatment recommendations for GI involvement in pSLE due to limited available data.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
(2021)
Review
Pediatrics
Angela Mauro, Teresa Giani, Clelia Di Mari, Martina Sandini, Antonella Talenti, Valentina Ansuini, Luigi Biondi, Giovanni Di Nardo, Luca Bernardo
Summary: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder. When it presents before the age of 18 years (childhood-onset systemic lupus erythematosus, cSLE), the disease course tends to be more severe with a higher rate of organ involvement and requires an early diagnosis. Gastrointestinal involvement in cSLE is rare and scarcely reported in the literature. This manuscript provides a narrative review of gastrointestinal manifestations in cSLE, focusing on hepatic, pancreatic, and intestinal involvement, based on a comprehensive literature search using the PubMed database.
Review
Dermatology
Joana Vieitez Frade, Paulo Filipe
Summary: This article reviews the current evidence for the treatment of cutaneous manifestations of lupus erythematosus in pregnant women, highlighting the challenges faced due to the lack of specific treatment recommendations and ethical considerations.
DERMATOLOGIC THERAPY
(2022)
Review
Oncology
Kaichi Kaneko, Hao Chen, Matthew Kaufman, Isaak Sverdlov, Emily M. Stein, Kyung-Hyun Park-Min
Summary: Osteonecrosis is a complex and devastating complication of systemic lupus erythematosus, with variable prevalence in SLE patients. The use of high-dose glucocorticoid therapy is strongly associated with the development of osteonecrosis in SLE patients, although the exact pathophysiology and risk factors for osteonecrosis in this population are not fully understood.
CLINICAL AND TRANSLATIONAL MEDICINE
(2021)
Review
Environmental Sciences
Paula Garcia-Rios, Maria Pilar Pecci-Lloret, Ricardo Elias Onate-Sanchez
Summary: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with oral manifestations such as oral ulcers, hyposalivation, and pigmentations. However, there is still insufficient research on these oral manifestations.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Review
Biochemistry & Molecular Biology
Valeria Rella, Cinzia Rotondo, Alberto Altomare, Francesco Paolo Cantatore, Addolorata Corrado
Summary: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations. Dysregulation of the immune system due to genetic, hormonal, and environmental factors can lead to various complications, including bone involvement such as osteoporosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Endocrinology & Metabolism
Rokayaa Abd El Aziz, Mary Wadie Fawzy, Noha Khalil, Sahar Abdel Atty, Zainab Sabra
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
(2018)
Article
Rheumatology
Mai A. Abd-Elmawla, Mary Wadie Fawzy, Sherine M. Rizk, Amira A. Shaheen
CLINICAL RHEUMATOLOGY
(2018)
Review
Cell Biology
Hala El-Gendy, Rasmia M. El-Gohary, Safaa Mahfouz, Hamdy M. A. Ahmed, Doaa M. El Demerdash, Gaafar Ragab
Article
Rheumatology
Ahmed Fayed, Rasmia Elgohary, Mary Fawzy
CLINICAL RHEUMATOLOGY
(2020)
Correction
Engineering, Biomedical
Jehan Alsharnoubi, Omnia Mohamed, Mary Fawzy
LASERS IN MEDICAL SCIENCE
(2021)
Article
Rheumatology
Amal El Beshlawy, Abd El Rahman Zekri, Manal S. Ramadan, Yasmeen M. M. Selim, Amina Abdel-Salam, Mohamed Tharwat Hegazy, Lamis Ragab, Carla Gaggiano, Luca Cantarini, Gaafar Ragab
Summary: This study investigates the genotype-phenotype associations of the three most common gene mutations in Egyptian FMF children. The results suggest that the genotype influences the clinical manifestations, disease severity, and response to colchicine.
CLINICAL RHEUMATOLOGY
(2022)
Article
Rheumatology
Hend Shater, Mary Fawzy, Alyaa Farid, Azza El-Amir, Salwa Fouad, Neveen Madbouly
Summary: This study found that serum IL-21 levels could serve as a diagnostic biomarker for active LN in Egyptian SLE patients, and correlated significantly with activity indexes of LN. Compared to BlyS and TNF-SF13, serum IL-21 showed superior diagnostic value.
Article
Rheumatology
Hanan M. Fathi, Mary W. Fawzy, Ihab I. Aboul-Eyon, Aya-tulla H. I. Eldesouky, Nahla N. Eesa
Summary: The study aimed to evaluate micro and macro-vascular involvement in systemic sclerosis (SSc) patients and their association with various disease parameters using non-invasive imaging techniques. The results showed distinct vascular alterations in SSc patients and highlighted the potential role of endothelial dysfunction in the development of vascular diseases.
EGYPTIAN RHEUMATOLOGIST
(2021)
Article
Medicine, General & Internal
Hend Shater, Mary Fawzy, Alyaa Farid, Azza El-Amir, Salwa Fouad, Neveen Madbouly
Summary: This study assessed the correlation of serum BAFF, APRIL, and IL-21 with carotid intima-media thickness (cIMT) as non-invasive biomarkers for the risk of premature atherosclerosis in patients with systemic lupus erythematosus (SLE). The results showed that BAFF and APRIL were correlated with disease activity and cIMT, suggesting their potential use as peripheral blood biomarkers for predicting premature atherosclerosis in SLE.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
(2022)
Review
Rheumatology
Yasser El Miedany, Sherif Ismail, Mary Wadie, Mohammed Hassan
Summary: The lack of familiarity with nailfold capillaroscopy technique and interpretation of its outcomes has hindered its utilization in standard clinical practice. However, as a non-invasive technique, nailfold capillaroscopy holds great potential as an outcome measure in research and for identifying underlying connective tissue diseases.
CLINICAL RHEUMATOLOGY
(2022)
Review
Immunology
Mohamed Tharwat Hegazy, Ahmed Fayed, Rossana Nuzzolese, Jurgen Sota, Gaafar Ragab
Summary: The kidney is an important target of systemic inflammation in autoinflammatory diseases (AIDs), showing a wide range of manifestations and potentially severe features. The pathogenesis of kidney involvement in AIDs is heterogeneous and can include amyloidosis and non-amyloid related damage caused by inflammasome activation. Various forms of glomerulonephritis, vascular disorders, and drug-induced nephrotoxicity can occur in AIDs patients, highlighting the need for routine assessment and early diagnosis through urinalysis, serum creatinine, proteinuria, hematuria, and imaging studies. The use of IL-1 inhibitors shows promise in managing kidney disease and improving long-term prognosis in AIDs patients.
IMMUNOLOGIC RESEARCH
(2023)
Article
Medicine, General & Internal
Mohamed A. Hussein, Mostafa Mahmoud Ramadan, Manal Abd El Moneam, Hanan Abd El Halim, Nagwa Abd El Ghaffar, Mary Wadie Fawzy
Summary: This study evaluated the relationship between arterial and microcirculation and serum IL-37 levels in Behçet's disease patients. It found that patients had higher carotid intima-media thickness, resistivity index, and peak-systolic velocity, and lower end-diastolic velocity, capillary loop, length, arterial and venous limb diameters, and serum IL-37 levels compared to healthy controls. The results suggest that IL-37 may be related to arterial stiffness in Behçet's disease.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
(2022)
Article
Rheumatology
Sameh Wadeea Bakhoum, Zeinab Ateya Ashour, Mahmood Sheikh Mohammed, Mary WadieFawzy
Summary: The study revealed alterations in LV function and increased LA stiffness in RA patients, with cardiac affection more commonly seen in seropositive patients.
EGYPTIAN RHEUMATOLOGIST
(2021)
Article
Urology & Nephrology
Ahmed Fayed, Amr Shaker, Wael M. Hamza, Mary Wadie
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION
(2019)
Article
Rheumatology
Manal El Menyawi, Mary Fawzy, Mohamed Habib, Olfat Shaker
ARCHIVES OF RHEUMATOLOGY
(2018)